0 7 Nuclear nuclear JJ 8 21 factor-kappaB factor-kappaB NNP 22 32 activation activation NN 33 35 in in IN 36 41 human human JJ 42 51 monocytes monocyte NNS 52 62 stimulated stimulate VBN 63 67 with with IN 68 86 lipopolysaccharide lipopolysaccharide NN 87 89 is be VBZ 90 99 inhibited inhibit VBN 100 102 by by IN 103 113 fibroblast fibroblast NN 114 125 conditioned conditioned JJ 126 132 medium medium NN 133 136 and and CC 137 146 exogenous exogenous JJ 147 151 PGE2 pge2 NN 151 152 . . . 154 157 The the DT 158 165 nuclear nuclear JJ 166 172 factor factor NN 173 179 kappaB kappaB NNP 180 181 ( ( ( 181 190 NF-kappaB NF-kappaB NNP 190 191 ) ) ) 192 194 is be VBZ 195 202 thought think VBN 203 205 to to TO 206 208 be be VB 209 218 crucially crucially RB 219 227 involved involve VBN 228 230 in in IN 231 234 the the DT 235 239 gene gene NN 240 250 activation activation NN 251 253 of of IN 254 261 several several JJ 262 271 cytokines cytokine NNS 271 272 , , , 273 282 including include VBG 283 288 tumor tumor NN 289 297 necrosis necrosis NN 298 304 factor factor NN 305 310 alpha alpha NN 311 312 ( ( ( 312 315 TNF TNF NNP 315 316 ) ) ) 316 317 . . . 318 328 Previously previously RB 328 329 , , , 330 332 we we PRP 333 339 showed show VBD 340 344 that that IN 345 355 fibroblast fibroblast NN 356 367 conditioned conditioned JJ 368 374 medium medium NN 375 376 ( ( ( 376 379 FCM FCM NNP 379 380 ) ) ) 381 383 is be VBZ 384 388 able able JJ 389 391 to to TO 392 399 inhibit inhibit VB 400 404 both both CC 405 408 TNF TNF NNP 409 413 mRNA mrna NN 414 426 accumulation accumulation NN 427 430 and and CC 431 438 protein protein NN 439 446 release release NN 447 449 in in IN 450 460 peripheral peripheral JJ 461 474 blood-derived blood-derived JJ 475 480 human human JJ 481 490 monocytes monocyte NNS 491 492 ( ( ( 492 495 PBM PBM NNP 495 496 ) ) ) 497 507 stimulated stimulate VBN 508 512 with with IN 513 531 lipopolysaccharide lipopolysaccharide NN 532 533 ( ( ( 533 536 LPS LPS NNP 536 537 ) ) ) 537 538 . . . 539 541 In in IN 542 546 this this DT 547 552 study study NN 553 555 we we PRP 556 560 have have VBP 561 573 investigated investigate VBN 574 577 the the DT 578 584 effect effect NN 585 587 of of IN 588 591 FCM FCM NNP 592 594 on on IN 595 598 the the DT 599 610 LPS-induced lps-induced JJ 611 622 DNA-binding dna-binding JJ 623 631 activity activity NN 632 634 of of IN 635 644 NF-kappaB NF-kappaB NNP 644 645 , , , 646 648 by by IN 649 654 means mean NNS 655 657 of of IN 658 673 electrophoretic electrophoretic JJ 674 679 shift shift NN 680 685 assay assay NN 686 687 ( ( ( 687 691 EMSA EMSA NNP 691 692 ) ) ) 692 693 . . . 694 696 We we PRP 697 704 provide provide VBP 705 713 evidence evidence NN 714 718 that that IN 719 722 FCM FCM NNP 723 731 strongly strongly RB 732 740 inhibits inhibit VBZ 741 744 the the DT 745 756 LPS-induced lps-induced JJ 757 766 NF-kappaB NF-kappaB NNP 767 777 activation activation NN 778 780 in in IN 781 784 PBM PBM NNP 784 785 . . . 786 797 Furthermore furthermore RB 797 798 , , , 799 801 we we PRP 802 806 show show VBP 807 811 that that IN 812 821 exogenous exogenous JJ 822 826 PGE2 pge2 NN 827 833 mimics mimic VBZ 834 837 the the DT 838 847 NF-kappaB NF-kappaB NNP 848 858 inhibitory inhibitory JJ 859 865 effect effect NN 866 868 of of IN 869 872 FCM FCM NNP 872 873 . . . 874 876 On on IN 877 880 the the DT 881 886 other other JJ 887 891 hand hand NN 891 892 , , , 893 896 FCM FCM NNP 897 905 produced produce VBN 906 908 in in IN 909 912 the the DT 913 921 presence presence NN 922 924 of of IN 925 937 indomethacin indomethacin NN 938 942 does do VBZ 943 946 not not RB 947 954 inhibit inhibit VB 955 964 NF-kappaB NF-kappaB NNP 965 975 activation activation NN 976 978 by by IN 979 982 LPS LPS NNP 982 983 . . . 984 987 Our our PRP$ 988 995 results result NNS 996 1000 lend lend VBP 1001 1008 further further JJ 1009 1016 support support NN 1017 1019 to to TO 1020 1023 the the DT 1024 1034 hypothesis hypothesis NN 1035 1039 that that IN 1040 1052 inflammatory inflammatory JJ 1053 1056 and and CC 1057 1063 immune immune JJ 1064 1073 responses response NNS 1074 1076 of of IN 1077 1098 monocytes/macrophages monocytes/macrophage NNS 1099 1102 may may MD 1103 1105 be be VB 1106 1115 modulated modulate VBN 1116 1118 at at IN 1119 1122 the the DT 1123 1132 molecular molecular JJ 1133 1138 level level NN 1139 1141 by by IN 1142 1149 signals signal NNS 1150 1161 originating originate VBG 1162 1166 from from IN 1167 1173 tissue tissue NN 1174 1184 structural structural JJ 1185 1190 cells cell NNS 1191 1195 such such JJ 1196 1198 as as IN 1199 1210 fibroblasts fibroblast NNS 1210 1211 . . .